You are here

Article metrics

Article menu
Download PDFPDF
Commentary
General medicine
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism

 

Online download statistics by month:

Online download statistics by month: June 2018 to November 2024

AbstractFullPdf
Jun 20186121
Jul 20183874829
Aug 2018209396
Sep 20182892511
Oct 201828995
Nov 20184242817
Dec 20183362318
Jan 2019167198
Feb 2019100104
Mar 20197841
Apr 20198831
May 20193321
Jun 20197622
Jul 20195254
Aug 20193731
Sep 20197852
Oct 20194572
Nov 20193343
Dec 20194221
Jan 20204002
Feb 20205521
Mar 20204910
Apr 20205020
May 20204812
Jun 20204610
Jul 20203032
Aug 20201800
Sep 20204730
Oct 20202321
Nov 20202710
Dec 20202400
Jan 20213721
Feb 20212010
Mar 20212400
Apr 20212300
May 20211400
Jul 2021110
Aug 2021110
Oct 20212102
Nov 20215821
Dec 20212241
Jan 20221800
Feb 20224210
Mar 20225710
Apr 20221701
May 20224922
Jun 20225110
Jul 20222421
Aug 20226510
Sep 20224540
Oct 20226930
Nov 20222400
Dec 2022900
Jan 20232411
Feb 20235310
Mar 20232800
Apr 20231000
May 20232400
Jun 2023311
Jul 20231400
Aug 20231800
Sep 20232720
Oct 20233710
Nov 20233741
Dec 20232812
Jan 2024800
Feb 2024900
Mar 20245022
Apr 20243700
May 20244800
Jun 20245010
Jul 20245300
Aug 20244420
Sep 20242311
Oct 20242834
Nov 20241700
Total4642302146